X

Trial Profile

A Multicentre Phase I Study Of Cremophor FreePaclitaxel Nanoparticle In Advanced Breast Cancer.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 09 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Paclitaxel (Primary)
Indications Advanced breast cancer
Focus Adverse reactions; Pharmacokinetics
Sponsors Fresenius Kabi

Most Recent Events

15 Feb 2012 Status changed from recruiting to completed as reported by Clinical Trials Registry - India
03 Jul 2009 New source identified and integrated (Clinical Trials Registry - India record no. CTRI2009-091-000219).
03 Jul 2009 Additional trial identifier UTRN115924240-290420096391230 and CTRI2009-091-000219 identified as reported by Clinical Trials Registry - India.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com